Nephrology

Of the 2199 patients who received a renal transplant, only 8 were treated for active tuberculosis.

For patients without diabetes, low serum bicarbonate and higher high sensitivity troponin T, NTproBNP, and urine NGAL were linked to a higher risk of the composite outcome.

Racial and ethnic disparities did not substantially improve between 2005-2015 for patients with end-stage kidney disease.

Antithrombotic agents caused 34% of serious adverse drug reactions identified in the study.

Tricida will meet with the FDA in an attempt to provide more data for the treatment of patients with chronic kidney disease.

There were no differences found in pulse wave velocity, augmentation index, or physical function between patients who took vitamin K supplements and patients given a placebo.

Categorizing baseline SCr as the median value over the preadmission period could be the least biased estimate of the baseline renal function.

Investigators find study drug was well-tolerated with no new safety concerns.

Less than 1% of nearly 500,000 hospitalized patients required kidney replacement therapy.

Canagliflozin is a known treatment for kidney disease, as well as heart failure in patients with type 2 diabetes and diabetic nephropathy.

There is a higher chronic kidney disease prevalence for individuals with lower educational levels.

Chronic kidney disease and kidney failure represent the most common comorbidities for patients hospitalized with COVID-19 infections.

The estimated two-year four-variable kidney failure risk equation for individual risk using predicted ACR from PCR had discrimination similar to that of using observed ACR.

Silvio Inzucchi, MD, discusses an EMPA-REG OUTCOME analysis assessing the impact of empagliflozin in patients who experience an initial dip in eGFR.

New research is shining light on the use of eGFR as a biomarker for increased cardiovascular risk.

The intravenous approach can be used regardless of what bicarbonate delivery method a dialysis center uses.

A discussion with a Brigham and Women's Hospital cardiologist on the research of the add-on cardiometabolic drug class.

Azathioprine is linked to a slightly higher eGFR for patients with inflammatory bowel disease.

Coronary microvascular dysfunction is independently related to abnormal cardiac mechanics, according to a new study.

Higher ACR levels following an acute kidney injury is linked to an increased risk of kidney disease progression.

In a new study, investigators determine the death-censored risk of graft failure with structural kidney feature.

Deceased donor kidneys could offer a solution to a major kidney shortage in the US.

In a new study, investigators suggest coffee may be used in prevention strategies for chronic kidney disease.

Discussing the key differences in the results of ISCHEMIA and ISCHEMIA-CKD, which examined whether the use of invasive or conservative strategies was more effective for patients with ischemic heart disease.

Michael Spigler, vice president of Patient Services and Kidney Disease Education for the American Kidney Fund, talks about the challenges and future of nephrology during Kidney Week.

Investigators examine how different supplementation impacts kidney function in patients with type 2 diabetes.

Investigators present data from the CREDENCE trial during AHA.

Taking a routine invasive approach had no impact on clinical outcomes or quality of life in patients with chronic kidney disease as well as stable ischemic heart disease.

With ARBs linked to a higher risk of suicide, investigators suggest treating diseases like hypertension, chronic kidney disease, heart failure, and diabetes with ACEIs instead.

The results of a new survey regarding quality of care for end stage renal disease patients raise questions about how to improve the quality of end-of-life care.